Skip to content

13F-HR filed by Birchview Capital, LP

Birchview Capital, LP filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-02, with 40 holding rows worth $193,591,000.

Accession
0001618205-17-000004
Filed
2017-11-02
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 0 entries on the cover page, a total value of $193,591,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $193,591,000 with VALUE read as thousands by filing date, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CELGENE CORP151020104COM761,051$110,976,000thousands by filing date
Accelerate Diagnostics00430H102COM2,183,795$49,026,000thousands by filing date
VERMILLION INC92407M206COM NEW2,462,933$4,433,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM52,400$3,211,000thousands by filing date
EQT CORP COM26884L109Stock42,300$2,760,000thousands by filing date
CORCEPT THERAPEUTICS INC218352102COM95,000$1,834,000thousands by filing date
QUIDEL CORP74838J101COM38,975$1,709,000thousands by filing date
ENCANA CORP292505104COM132,300$1,558,000thousands by filing date
ADVANCED ACCELERATOR APPLIC SPONSORED ADS00790T100ADR22,000$1,488,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS77,303$1,299,000thousands by filing date
CONTRAFECT CORP212326102COM1,135,082$1,260,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM68,000$1,217,000thousands by filing date
VERACYTE INC COM92337F107Stock118,767$1,042,000thousands by filing date
SIENTRA INC82621J105COM63,300$975,000thousands by filing date
ACCELERON PHARMA INC00434H108COM25,000$933,000thousands by filing date
SINGLE TOUCH SYSTEMS INC82988R203COM120,000$857,000thousands by filing date
WRIGHT MED GROUP INC98235T107COM30,000$776,000thousands by filing date
BIOLASE INC090911108COMMON STOCK1,285,903$775,000thousands by filing date
YIELD10 BIOSCIENCE INC98585K102COM226,317$722,000thousands by filing date
MASIMO CORP COM574795100Stock8,000$692,000thousands by filing date
TESARO INC881569107COM5,200$671,000thousands by filing date
Merck & Co.,Inc.58933Y105COM10,000$640,000thousands by filing date
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK24,000$494,000thousands by filing date
PIONEER NATURAL RESOURCES CO723787107COM3,000$443,000thousands by filing date
CELGENE CORP151020112RIGHT 12/31/2030291,877$443,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM5,000$412,000thousands by filing date
CLEMENTIA PHARMACEUTICALS IN185575107COM22,000$372,000thousands by filing date
BIOGEN INC COM09062X103Stock1,000$313,000thousands by filing date
QUOTIENT LTDG73268107SHS59,700$294,000thousands by filing date
XENCOR INC98401F105COMMON STOCK12,300$282,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM45,000$259,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM4,300$250,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock3,632$235,000thousands by filing date
AEVI GENOMIC MEDICINE INC00835P105COM128,000$161,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333XAD0DBCV 2.250% 6/110,000$158,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM10,000$151,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW10,000$145,000thousands by filing date
WORKHORSE GROUP INC98138J206COM NEW50,000$138,000thousands by filing date
ONCOMED PHARMACEUTICALS INC COM68234X102Stock28,689$130,000thousands by filing date
GENOCEA BIOSCIENCES INC372427104COM39,000$57,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001618205-17-000004this filing2017-11-02acceptance time not in the bulk data set